Rebus Biosystems specializes in advanced spatial omics technologies, primarily through their flagship product, the Rebus Esper™ platform. This fully integrated and automated instrument is designed to provide high-throughput, quantitative data at the single-molecule and single-cell levels, all while preserving the spatial context of biological samples. The Rebus Esper utilizes patented Synthetic Aperture Optics (SAO) to achieve exceptional resolution and speed, enabling researchers to analyze cells in their native tissue environments. With capabilities such as deep tissue imaging and a wide field of view, the platform allows for the processing of multiple samples simultaneously, significantly reducing costs and variability in experimental results.

The technology behind the Rebus Esper is aimed at enhancing biological research across various fields, including neuroscience, cancer, and immunology. By generating subcellular and single-cell data, the platform facilitates a deeper understanding of cell states and interactions within their microenvironments. The ease of use and automated workflow of the Rebus Esper allows researchers to focus on data interpretation rather than technical complexities, making it a valuable tool for uncovering new insights in disease biology and developmental processes.

United States

At Rebus Biosystems, our vision is spatial omics without compromise. Get subcellular resolution of biological molecules directly in and across large tissue sections. Customizable assays allow you to focus on the targets that matter most to your research. Available as a fully automated, integrated instrument for your lab in early 2021. Get access now available through our Spatial Omics as a Service program.

Rebus Biosystems

Company Details